AI-assisted, human-published

11/03/2025 /M & A

Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal

vitamin b  effervescent  tablet  supplement  good health  exercise  health  lifestyle  diet  workout  weight  nutrition  training  vitamins  health drink  fizzy  energy  wellness  glass  sport  fitness  vitamin b  vitamin b  vitamin b  effervescent  effervescent  supplement  supplement  supplement  supplement  supplement  good health  fitness
AI-assisted, human-published

Kimberly-Clark Corporation has struck a deal to acquire Kenvue Inc. for approximately $48.7 billion. The acquisition is expected to create a powerhouse of complementary consumer products, including 10 billion-dollar brands. The combined entity will focus on leveraging its commercial engine, strategic partnerships, industry-leading science and innovation, digital model, marketing, and operational excellence to cater to consumers' evolving needs.

 

The transaction is projected to generate approximately $2.1 billion in run-rate synergies and is likely to be accretive to Kimberly-Clark's adjusted EPS by year 2. The deal will see Kenvue shareholders receiving $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. The agreement has been unanimously approved by the boards of both companies and is expected to close in the second half of 2026, subject to regulatory and shareholder approvals. Upon closure, Kimberly-Clark shareholders are anticipated to own about 54% of the combined company, while Kenvue shareholders are expected to hold approximately 46%.

 

The combined entity will retain its headquarters in Irving, Texas, and maintain a significant presence in Kenvue's locations. Kimberly-Clark and Kenvue will host a joint investor conference call today to discuss the transaction. The acquisition's financial advisors are PJT Partners LP and J.P. Morgan Securities LLC for Kimberly-Clark, and Centerview Partners LLC and Goldman Sachs & Co. LLC for Kenvue.

 

Read more about the deal here

Featured










Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com